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ABSTRACT
Background The WHO and National Institute for 
Health and Care Excellence recommend various triage 
tools to assist decision- making for patients with 
suspected COVID-19. We aimed to compare the accuracy 
of triage tools for predicting severe illness in adults 
presenting to the ED with suspected COVID-19.
Methods We undertook a mixed prospective and 
retrospective observational cohort study in 70 EDs 
across the UK. We collected data from people attending 
with suspected COVID-19 and used presenting data 
to determine the results of assessment with the WHO 
algorithm, National Early Warning Score version 2 
(NEWS2), CURB-65, CRB-65, Pandemic Modified Early 
Warning Score (PMEWS) and the swine flu adult hospital 
pathway (SFAHP). We used 30- day outcome data (death 
or receipt of respiratory, cardiovascular or renal support) 
to determine prognostic accuracy for adverse outcome.
Results We analysed data from 20 891 adults, of whom 
4611 (22.1%) died or received organ support (primary 
outcome), with 2058 (9.9%) receiving organ support and 
2553 (12.2%) dying without organ support (secondary 
outcomes). C- statistics for the primary outcome were: 
CURB-65 0.75; CRB-65 0.70; PMEWS 0.77; NEWS2 
(score) 0.77; NEWS2 (rule) 0.69; SFAHP (6- point rule) 
0.70; SFAHP (7- point rule) 0.68; WHO algorithm 0.61. All 
triage tools showed worse prediction for receipt of organ 
support and better prediction for death without organ 
support. At the recommended threshold, PMEWS and the 
WHO criteria showed good sensitivity (0.97 and 0.95, 
respectively) at the expense of specificity (0.30 and 0.27, 
respectively). The NEWS2 score showed similar sensitivity 
(0.96) and specificity (0.28) when a lower threshold than 
recommended was used.
Conclusion CURB-65, PMEWS and the NEWS2 score 
provide good but not excellent prediction for adverse 
outcome in suspected COVID-19, and predicted death 
without organ support better than receipt of organ 
support. PMEWS, the WHO criteria and NEWS2 (using 
a lower threshold than usually recommended) provide 
good sensitivity at the expense of specificity.
Trial registration number ISRCTN56149622.
INTRODUCTION
The ED has a crucial role in the management 
of patients with suspected COVID-19. ED 
management involves assessing the risk of adverse 
outcome and the need for life- saving interven-
tion, and then using this to determine deci-
sions around admission to hospital and inpatient 
referral.1 2 Triage tools can assist decision- making 
by combining information from clinical assess-
ment in a structured manner to predict the risk of 
adverse outcome. Triage tools may take the form 
of a score, which allocates points to risk predictors 
to indicate an increasing risk of adverse outcome, 
or a rule, which uses risk predictors to determine 
a clinical decision, such as hospital admission or 
discharge. Adults and children presenting to the ED 
with suspected COVID-19 differ markedly in their 
need for hospital admission and risk of adverse 
outcome,3 so they require different triage tools. We 
focus on adults in this study.
Guidelines have recommended a number of triage 
tools for adults with suspected COVID-19. The 
WHO decision- making algorithm for acute respira-
tory infection4 recommends hospital admission for 
Key messages
What is already known on this subject
 ► Emergency management of suspected 
COVID-19 involves predicting the risk of 
adverse outcome to determine the need for 
hospital admission.
 ► A number of triage tools have been 
recommended to support decision- making in 
suspected COVID-19, but accuracy for adverse 
outcome in suspected COVID-19 is not known.
What this study adds
 ► CURB-65, Pandemic Modified Early Warning 
Score (PMEWS) and National Early Warning 
Score version 2 (NEWS2) provide good but not 
excellent prediction for adverse outcome in 
suspected COVID-19.
 ► Triage tools predict death without organ 
support better than need for organ support.
 ► PMEWS, the WHO criteria and NEWS2 (using 
a lower threshold than usually recommended) 
can provide good sensitivity at the expense of 
specificity.
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severe pneumonia (RR >30/min, oxygen saturation <90% or 
signs of respiratory distress) or respiratory infection associated 
with comorbidities (age >60, hypertension, diabetes, cardiovas-
cular disease, chronic respiratory disease, chronic renal disease 
or immunocompromising conditions). The UK National Insti-
tute for Health and Care Excellence COVID-19 rapid guide-
line5 suggests that the National Early Warning Score version 2 
(NEWS2) score6 can be useful for predicting the risk of deteri-
oration. NEWS2 uses HR, RR, systolic BP, oxygen saturation, 
temperature and conscious level to allocate a score between 
0 and 20. The guideline also notes that the CRB-65 tool can 
determine the need for hospital admission in adults with pneu-
monia but has not been validated in people with COVID-19. 
The CURB-65 pneumonia score7 uses five variables (confusion, 
urea level, RR, BP and age) to generate a score between 0 and 5. 
The CRB-65 score allows use without blood testing by dropping 
urea measurement from the score.
Triage tools developed or recommended for an influenza 
pandemic could be used for suspected COVID-19. Guidance 
during the 2009 H1N1 pandemic included a swine flu adult 
hospital pathway for ED management with seven criteria, any one 
of which predicts increased risk and the need for hospital assess-
ment.8 The Pandemic Modified Early Warning Score (PMEWS)9 
uses physiological variables, age, social factors, chronic disease 
and performance status to generate a score between 0 and 19.
Aims and objectives
We aimed to compare the accuracy of triage tools recommended 
for predicting severe illness in adults presenting to the ED with 
suspected COVID-19 infection.
METHODS
We developed the Pandemic Influenza Triage in the Emer-
gency Department (PAINTED) study following the 2009 H1N1 
pandemic to evaluate triage tools for suspected pandemic 
influenza. We modified the PAINTED protocol to become 
the Pandemic Respiratory Infection Emergency System Triage 
(PRIEST) study in January 2020 to address any pandemic respi-
ratory infection and include triage tools recommended for 
COVID-19.
We undertook an observational study to collect standardised 
predictor variables recorded in the ED, which we then used to 
evaluate triage tools for predicting adverse outcome up to 30 
days after initial hospital presentation. The study did not involve 
any change to patient care. Hospital admission and discharge 
decisions were made according to usual practice, informed by 
local and national guidance.
We identified consecutive patients presenting to the ED of 
participating hospitals with suspected COVID-19 infection. 
Patients were eligible if they met the clinical diagnostic criteria10 
of fever (≥37.8°C) and acute onset of persistent cough (with 
Table 1 Characteristics of the study population
Characteristic Statistic/level
Age (years) n 20 891
  Mean (SD) 62.4 (19.7)
  Median (IQR) 64 (48, 79)
Sex Missing 193
  Male 10 201 (49.3%)
  Female 10 497 (50.7%)
Ethnicity Missing/prefer not to say 4198
  UK/Irish/other white 14 243 (85.3%)
  Asian 1044 (6.3%)
  Black/African/Caribbean 640 (3.8%)
  Mixed/multiple ethnic groups 247 (1.5%)
  Other 519 (3.1%)
Presenting features Cough 12 985 (62.2%)
  Shortness of breath 15 570 (74.5%)
  Fever 10 276 (49.2%)
Symptom duration (days) n 18 877
  Mean (SD) 7.9 (8.9)
  Median (IQR) 5 (2, 10)
HR (beats/min) n 20 460
  Mean (SD) 94.9 (21.6)
  Median (IQR) 93 (80, 108)
RR (breaths/min) n 20 346
  Mean (SD) 23.3 (7)
  Median (IQR) 22 (18, 26)
Systolic BP (mm Hg) n 20 298
  Mean (SD) 134.6 (24.9)
  Median (IQR) 133 (118, 149)
Diastolic BP (mm Hg) n 20 212
  Mean (SD) 78.2 (16.1)
  Median (IQR) 78 (68, 88)
Temperature (°C) n 20 231
  Mean (SD) 37.1 (1.1)
  Median (IQR) 37 (36.4, 37.8)
Oxygen saturation (%) n 20 632
  Mean (SD) 94.7 (6.8)
  Median (IQR) 96 (94, 98)
GCS n 15 428
  Mean (SD) 14.6 (1.4)
  Median (IQR) 15 (15, 15)
AVPU Missing 2387
  Alert 17 568 (94.9%)
  Verbal 640 (3.5%)
  Pain 183 (1%)
  Unresponsive 113 (0.6%)
Comorbidities Hypertension 6434 (30.8%)
Heart disease 4700 (22.5%)
Diabetes 4129 (19.8%)
Other chronic lung disease 3764 (18%)
Asthma 3408 (16.3%)
Renal impairment 1930 (9.2%)
Active malignancy 1120 (5.4%)
Steroid therapy 557 (2.7%)
No chronic disease 5791 (27.7%)
Performance status Missing 1078
Unrestricted normal activity 10 536 (53.2%)





Limited activity, can self- care 2776 (14%)
Limited self- care 2649 (13.4%)
Bed/chair bound, no self- care 1481 (7.5%)
Other clinical concern Severe respiratory distress 587 (2.8%)
  Respiratory exhaustion 292 (1.4%)
  Severe dehydration 261 (1.2%)
AVPU, Alert Verbal Pain Unresponsive.
Table 1 Continued
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or without sputum), hoarseness, nasal discharge or congestion, 
shortness of breath, sore throat, wheezing and sneezing. This 
was determined on the basis of the assessing clinician recording 
that the patient had suspected COVID-19 or completing a stan-
dardised assessment form designed for suspected pandemic 
respiratory infection.11
We planned to evaluate triage tools recommended for use in 
the COVID-19 pandemic or the 2009 H1N1 influenza pandemic, 
as outlined in the Introduction section: the WHO algorithm, 
NEWS2, CURB-65, CRB-65, PMEWS and the swine flu adult 
hospital pathway (SFAHP). The triage tools are described in 
online supplemental appendix 1. NEWS2 can be used as a score, 
with thresholds between 0 and 20 on the total score, or a rule, 
with a single threshold of a total score greater than 4 or a score 
of 3 on any parameter. We therefore evaluated the performance 
of NEWS2 as both a score and a rule. The SFAHP has a criterion 
(G) that is positive if there is any clinical concern. This is diffi-
cult to judge objectively or identify from clinical records, so we 
evaluated the pathway in two ways: (1) a 6- point rule that did 
not include parameter G; (2) a 7- point rule in which parameter 
G was positive if the NEWS2 rule was positive. NEWS2 is widely 
used in the UK health service to identify clinical concern.
Data collection was both prospective and retrospective. We 
provided participating EDs with a standardised data collection 
form that included the predictor variables used in the triage 
tools.11 Participating sites could adapt the form to their local 
circumstances, including integrating it into electronic or paper 
clinical records to facilitate prospective data collection, or using 
it as a template for research staff to retrospectively extract data 
from clinical records. We did not seek consent to collect data but 
information about the study was provided in the ED and patients 
could withdraw their data at their request. Patients with multiple 
presentations to hospital were only included once, using data 
from the first presentation identified by research staff.
Research staff at participating hospitals reviewed patient 
records at 30 days after initial attendance to identify any adverse 
outcomes. Patients who died or required respiratory, cardio-
vascular or renal support were classified as having an adverse 
outcome. Patients who survived to 30 days without requiring 
respiratory, cardiovascular or renal support were classified as 
having no adverse outcome. Respiratory support was defined 
as any intervention to protect the patient’s airway or assist 
their ventilation, including non- invasive ventilation or acute 
administration of continuous positive airway pressure. It did 
not include supplemental oxygen alone or nebulised broncho-
dilators. Cardiovascular support was defined as any interven-
tion to maintain organ perfusion, such as inotropic drugs, or 
invasively monitor cardiovascular status, such as central venous 
pressure or pulmonary artery pressure monitoring, or arterial BP 
monitoring. It did not include peripheral intravenous cannula-
tion or fluid administration. Renal support was defined as any 
intervention to assist renal function, such as haemofiltration, 
haemodialysis or peritoneal dialysis. It did not include intrave-
nous fluid administration.
The primary outcome was death, or respiratory, cardio-
vascular or renal support, as defined above. We also planned 
secondary analyses using the following outcomes: (1) respira-
tory, cardiovascular or renal support to predict need for life- 
saving treatment; (2) death without respiratory, cardiovascular 
or renal support to predict poor prognosis. If triage tools are 
used to determine treatment decisions, such as referral to critical 
care, then it is helpful to know how well they predict need for 
treatment rather than a potentially irremediable poor prognosis.
We retrospectively applied each triage tool to the data, 
excluding pregnant women from analysis of NEWS2. Online 
supplemental appendix 1 provides details of scoring and 
handling missing data for the triage tools. For each tool we 
plotted the receiver operating characteristic (ROC) curve and 
calculated the area under the ROC curve (c- statistic) for discrim-
inating between cases with and without adverse outcome. We 
calculated sensitivity, specificity, positive predictive value and 
negative predictive value at the following prespecified decision- 
making thresholds based on recommended or usual use: 0–1 vs 
2–5 for CURB-65; 0–2 vs 3+ for PMEWS; 0–4 vs 5–20 for the 
NEWS2 score. The WHO algorithm and swine flu adult hospital 
pathway are positive if any criterion is positive. We used STATA 
(V.16) for analyses.12
The sample size was dependent on the size and severity of 
the pandemic, but based on a previous study in the 2009 H1N1 
influenza pandemic we estimated we would need to collect data 
from 20 000 patients across 40–50 hospitals to identify 200 with 
an adverse outcome. In the event, the adverse outcome rate in 
adults was much higher in the COVID-19 pandemic, giving us 
adequate power to undertake primary and secondary analyses.
Patient and public involvement
The Sheffield Emergency Care Forum (SECF) is a public 
representative group interested in emergency care research.13 
Members of SECF advised on the development of the PRIEST 
study and two members joined the Study Steering Committee. 
Patients were not involved in the recruitment to and conduct 
of the study. We are unable to disseminate the findings to study 
participants directly.
RESULTS
The PRIEST study recruited 22 484 patients from 70 EDs across 
53 sites between 26 March and 28 May 2020. We included 
Table 2 Summary of ROC analysis for existing triage tools predicting adverse outcomes







CURB-65 20 716 0.75 (0.74, 0.76) (>1) 0.71 (0.70 to 0.72) 0.69 (0.69 to 0.70) 0.40 (0.39 to 0.41) 0.89 (0.89 to 0.90) 0.39
CRB-65 20 716 0.70 (0.69, 0.70) (>0) 0.86 (0.85 to 0.87) 0.48 (0.47 to 0.48) 0.32 (0.31 to 0.33) 0.92 (0.92 to 0.93) 0.60
PMEWS 20 492 0.77 (0.76, 0.77) (>2) 0.97 (0.96 to 0.97) 0.30 (0.30 to 0.31) 0.28 (0.27 to 0.29) 0.97 (0.96 to 0.97) 0.76
NEWS2 (score) 20 594 0.77 (0.76, 0.78) (>4) 0.77 (0.76 to 0.78) 0.64 (0.63 to 0.65) 0.38 (0.37 to 0.39) 0.90 (0.90 to 0.91) 0.45
NEWS2 (rule) 20 594 0.69 (0.68, 0.69) (>0) 0.83 (0.82 to 0.84) 0.55 (0.54 to 0.55) 0.34 (0.33 to 0.35) 0.92 (0.91 to 0.92) 0.54
SFAHP (6- point rule) 19 858 0.70 (0.69, 0.71) (>0) 0.74 (0.73 to 0.75) 0.66 (0.65 to 0.67) 0.38 (0.37 to 0.39) 0.90 (0.89 to 0.90) 0.43
SFAHP (7- point rule) 20 682 0.68 (0.68, 0.69) (>0) 0.88 (0.87 to 0.89) 0.48 (0.48 to 0.49) 0.33 (0.32 to 0.33) 0.94 (0.93 to 0.94) 0.60
WHO algorithm 20 891 0.61 (0.61, 0.62) (>0) 0.95 (0.95 to 0.96) 0.27 (0.26 to 0.28) 0.27 (0.26 to 0.28) 0.95 (0.95 to 0.96) 0.78
NEWS2, National Early Warning Score version 2; PMEWS, Pandemic Modified Early Warning Score; ROC, receiver operating characteristic; SFAHP, swine flu adult hospital pathway.
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20 891 in the analysis after excluding 39 who requested with-
drawal of their data, 1530 children, 7 with missing age and 17 
with missing outcome data.
Table 1 shows the characteristics of adults in the cohort. Some 
13 997 (67.0%) were admitted after ED assessment and 6521 
(31.2%) ultimately tested positive for COVID-19. Overall, 4611 
(22.1%) died or received organ support (primary outcome), with 
2058 (9.9%) receiving organ support and 2553 (12.2%) dying 
without organ support (secondary outcomes). Organ support 
involved respiratory support for 1944 (9.3%), cardiovascular 
for 517 (2.5%) and renal support for 218 (1%).
Table 2 shows the results for the primary analysis, table 3 the 
results for secondary analysis predicting receipt of organ support 
and table 4 the results for secondary analysis predicting death 
without organ support. The ROC curves for these analyses are 
shown in figures 1–3.
In the primary analysis presented in table 2, none of the 
triage tools showed excellent discrimination (c- statistic 
>0.8) but CURB-65, PMEWS and the NEWS2 score showed 
good discrimination (>0.7). This may reflect the use of 
multiple points across these tools, as opposed to a single 
decision- making threshold for other tools. At the prespeci-
fied threshold, PMEWS and the WHO criteria showed good 
sensitivity (0.97 and 0.95, respectively) at the expense of 
specificity (0.30 and 0.27, respectively). The sensitivities of 
other triage tools at the prespecified threshold were below 
0.9, although with higher specificities. A sensitivity analysis 
of the NEWS2 score including 85 pregnant women who were 
excluded from the primary analysis produced no change in 
the c- statistic (and CI).
The triage tools generally showed worse prediction for 
receipt of organ support and better prediction for death 
without organ support. This was most marked for CURB-65 
and CRB-65, and least marked for the NEWS2 score. Only 
the NEWS2 score showed good prediction for organ support 
(c- statistic >0.7).
Online supplemental table S1 shows the sensitivity 
and specificity at each threshold for the triage tools with 
multiple potential thresholds for decision- making (CURB-
65, CRB-65, PMEWS and NEWS2). These results suggest 
that NEWS2 score could offer good sensitivity (0.96) at the 
expense of specificity (0.28), if we use a score greater than 
1 to predict adverse outcome. The sensitivity of CURB-65 is 
0.90 and CRB-65 is 0.86 at the lowest threshold (any score 
above 0 predicts adverse outcome).
Online supplemental table S2 shows the proportion with 
an adverse outcome at each level of each score. This analysis 
shows that patients with a risk of adverse outcome of 5% or 
less could be identified using the WHO algorithm, a NEWS2 
score of 0–1 or a PMEWS score of 0–2.
DISCUSSION
ED clinicians usually use triage tools to support decisions, 
such as admission to hospital, where sensitivity needs to 
be optimised at the expense of specificity to avoid missed 
opportunities to predict and prevent adverse outcome. Our 
analysis suggests that the WHO algorithm or PMEWS greater 
than 2 provide good sensitivity at the expense of specificity, 
and could be used to support decision- making where sensi-
tivity needs to be optimised. The NEWS2 score needs to 
use a lower threshold (any score above 1) than currently 
recommended to achieve a comparable balance of sensitivity 
and specificity.
The triage tools predicted death without organ support 
better than they predicted receipt of organ support. Only the 
NEWS2 score predicted receipt of organ support with good 
accuracy. This reflects NEWS2 using only physiological 
Table 3 Summary of ROC analysis for existing triage tools predicting organ support







CURB-65 20 716 0.60 (0.59, 0.61) (>1) 0.52 (0.50 to 0.54) 0.62 (0.61 to 0.63) 0.13 (0.12 to 0.14) 0.92 (0.92 to 0.93) 0.39
CRB-65 20 716 0.58 (0.56, 0.59) (>0) 0.74 (0.72 to 0.76) 0.42 (0.41 to 0.42) 0.12 (0.12 to 0.13) 0.94 (0.93 to 0.94) 0.60
PMEWS 20 492 0.68 (0.67, 0.69) (>2) 0.94 (0.93 to 0.95) 0.27 (0.26 to 0.27) 0.12 (0.12 to 0.13) 0.98 (0.97 to 0.98) 0.76
NEWS2 (score) 20 594 0.72 (0.71, 0.73) (>4) 0.76 (0.74 to 0.78) 0.58 (0.58 to 0.59) 0.17 (0.16 to 0.17) 0.96 (0.95 to 0.96) 0.45
NEWS2 (rule) 20 594 0.65 (0.64, 0.66) (>0) 0.81 (0.79 to 0.83) 0.49 (0.49 to 0.50) 0.15 (0.14 to 0.16) 0.96 (0.96 to 0.96) 0.54
SFAHP (6- point rule) 19 858 0.64 (0.63, 0.65) (>0) 0.68 (0.66 to 0.71) 0.60 (0.59 to 0.61) 0.16 (0.15 to 0.17) 0.95 (0.94 to 0.95) 0.43
SFAHP (7- point rule) 20 682 0.65 (0.64, 0.65) (>0) 0.86 (0.84 to 0.87) 0.43 (0.42 to 0.44) 0.14 (0.14 to 0.15) 0.97 (0.96 to 0.97) 0.60
WHO algorithm 20 891 0.57 (0.57, 0.58) (>0) 0.91 (0.90 to 0.92) 0.24 (0.23 to 0.24) 0.12 (0.11 to 0.12) 0.96 (0.96 to 0.97) 0.78
NEWS2, National Early Warning Score version 2; PMEWS, Pandemic Modified Early Warning Score; ROC, receiver operating characteristic; SFAHP, swine flu adult hospital pathway.
Table 4 Summary of ROC analysis for existing triage tools predicting death without organ support







CURB-65 20 716 0.82 (0.82, 0.83) (>1) 0.86 (0.85 to 0.87) 0.67 (0.66 to 0.68) 0.27 (0.26 to 0.28) 0.97 (0.97 to 0.97) 0.39
CRB-65 20 716 0.75 (0.75, 0.76) (>0) 0.96 (0.95 to 0.97) 0.45 (0.44 to 0.46) 0.20 (0.19 to 0.20) 0.99 (0.98 to 0.99) 0.60
PMEWS 20 492 0.78 (0.77, 0.78) (>2) 0.99 (0.98 to 0.99) 0.28 (0.27 to 0.28) 0.16 (0.15 to 0.17) 0.99 (0.99 to 0.99) 0.76
NEWS2 (score) 20 594 0.75 (0.74, 0.76) (>4) 0.78 (0.76 to 0.79) 0.60 (0.59 to 0.60) 0.21 (0.20 to 0.22) 0.95 (0.95 to 0.95) 0.45
NEWS2 (rule) 20 594 0.67 (0.67, 0.68) (>0) 0.84 (0.83 to 0.86) 0.51 (0.50 to 0.51) 0.19 (0.18 to 0.20) 0.96 (0.95 to 0.96) 0.54
SFAHP (6- point rule) 19 858 0.70 (0.69, 0.71) (>0) 0.78 (0.77 to 0.80) 0.62 (0.61 to 0.63) 0.22 (0.21 to 0.23) 0.95 (0.95 to 0.96) 0.43
SFAHP (7- point rule) 20 682 0.67 (0.67, 0.68) (>0) 0.90 (0.89 to 0.91) 0.45 (0.44 to 0.45) 0.18 (0.18 to 0.19) 0.97 (0.97 to 0.97) 0.60
WHO algorithm 20 891 0.62 (0.61, 0.62) (>0) 0.99 (0.98 to 0.99) 0.25 (0.24 to 0.26) 0.15 (0.15 to 0.16) 0.99 (0.99 to 0.99) 0.78
NEWS2, National Early Warning Score version 2; PMEWS, Pandemic Modified Early Warning Score; ROC, receiver operating characteristic; SFAHP, swine flu adult hospital pathway.
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measures, while other triage tools include age, performance 
status or comorbidities that are more likely to predict death 
without organ support.
Studies undertaken during the 2009 H1N1 influenza 
pandemic suggested that existing triage tools have suboptimal 
accuracy for predicting adverse outcome in acute respiratory 
infections, with c- statistics below 0.8.14–16 Recent studies 
have evaluated NEWS2, CURB-65 and CRB-65 in adult 
inpatients with confirmed COVID-19. Fan et al (n=654)17 
reported c- statistics of 0.81, 0.85 and 0.80, respectively, for 
NEWS2, CURB-65 and CRB-65 as predictors of in- hospital 
death. The conventional thresholds for positivity of scores 
above 4, 1 and 0 offered suboptimal sensitivity (0.79, 0.63 
and 0.83), with corresponding specificities of 0.69, 0.91 and 
0.69. Bradley et al (n=830)18 reported c- statistics of 0.67 
for NEWS2 and 0.74 for CURB-65 as predictors of 30- day 
mortality, with sensitivities and specificities at conventional 
thresholds of 0.83 and 0.37 for NEWS2, and 0.80 and 0.59 
for CURB-65. Ma et al (n=305)19 reported c- statistics of 
0.79 for NEWS2 and 0.85 for CURB-65 for predicting 
death. Satici et al (n=681)20 reported a c- statistic of 0.79 for 
predicting 30- day mortality with CURB-65, with sensitivity 
of 0.73 and specificity of 0.85 at the conventional threshold. 
Nguyen et al21 reported that 36/171 (21%) patients with 
CURB-65 scores of 0 or 1 died or received intensive care 
admission. Gidari et al (n=68)22 evaluated NEWS2 as a 
predictor of intensive care admission and Myrstad et al 
(n=66)23 evaluated NEWS2 and CRB-65 as predictors 
of death or intensive care admission, but the small sizes 
produced imprecise estimates of prognostic parameters.
These studies concur with our findings that the conven-
tional thresholds for NEWS2 and CURB-65 offer inad-
equate sensitivity to support discharge decisions after ED 
assessment. The larger studies used 30- day or in- hospital 
mortality as their outcome. Our analysis suggests that this 
may overestimate prognostic accuracy if the tools are used 
to predict need for life- saving treatment rather than simply 
predicting mortality.
We collected data from a clinically relevant population of 
patients presenting with suspected COVID-19 across a large 
and varied range of EDs. The large sample size and high rate 
of adverse outcome allowed us to estimate parameters with 
a high degree of precision in primary and secondary anal-
yses. The main limitation is that the triage tools applied to 
data collected from clinical record review or a standardised 
data collection form, rather than being applied directly to 
the patient by the assessing clinician. This may have led to 
underestimation of the performance of the triage tool, espe-
cially when relevant data were missing. Table 1 shows that 
data were relatively complete for age, physiological variables 
and performance status, but the recording of other param-
eters (respiratory distress, respiratory exhaustion, dehy-
dration) was limited by inability to determine whether the 
feature was not present or not recorded. This is most salient 
for the swine flu adult hospital pathway and may have led 
to underestimation of the sensitivity of this triage tool. 
Another potential limitation is that we may have missed 
adverse outcomes if patients attended a different hospital 
after initial hospital discharge. This is arguably less likely 
in the context of a pandemic, in which movements between 
regions were curtailed, but cannot be discounted. Finally, 
although some triage tools can be used in the prehospital or 
community setting, we recommend caution in extrapolating 
our findings to other settings, where there may be a lower 
prevalence of adverse outcome.
The clinical utility of our findings needs careful interpre-
tation. Triage tools should not be used as the sole (or even 
principal) criteria for decision- making but should be used 
alongside clinical judgement. Our analysis did not evaluate 
how triage tools perform alongside or in comparison to clin-
ical judgement. Further research would be helpful to explore 
this issue and determine how triage tools are best used in 
practice. Furthermore, although predicting death and need 
for organ support is clearly important to decision- making, 
Figure 1 Overlaid receiver operating characteristic (ROC) curves for 
triage tools predicting adverse outcome in adults. NEWS2, National 
Early Warning Score version 2; PMEWS, Pandemic Modified Early 
Warning Score; SFAHP, swine flu adult hospital pathway.
Figure 2 Overlaid receiver operating characteristic (ROC) curves for 
triage tools predicting any support in adults. NEWS2, National Early 
Warning Score version 2; PMEWS, Pandemic Modified Early Warning 
Score; SFAHP, swine flu adult hospital pathway.
Figure 3 Overlaid receiver operating characteristic (ROC) curves 
for triage tools predicting death without support in adults. NEWS2, 
National Early Warning Score version 2; PMEWS, Pandemic Modified 
Early Warning Score; SFAHP, swine flu adult hospital pathway.
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there are other factors that may determine hospital admis-
sion decisions. For example, it would be helpful to predict 
the need for supplemental oxygen. We excluded this from 
our outcome definition because use of supplemental oxygen 
may be poorly recorded and as a simple intervention it may 
be used when not clearly indicated. However, there is no 
doubt that some patients in our cohort will have required 
supplemental oxygen and will not have met our definition of 
an adverse outcome.
Our findings suggest that the WHO algorithm or PMEWS 
greater than 2 could be used to support hospital admission 
decisions, providing good sensitivity at the expense of spec-
ificity. The NEWS2 score would need to use a threshold 
greater than 1 to achieve a similar balance of sensitivity 
and specificity. If a triage tool is used to select patients for 
higher levels of treatment, rather than simply predict risk of 
adverse outcome, then NEWS2 offers better discrimination 
than other triage tools. Use of triage tools for this purpose 
may also require a different balance of sensitivity and spec-
ificity, with a higher threshold being used to ensure higher 
levels of care are reserved for those most likely to benefit.
In general, however, the accuracy of the triage tools eval-
uated was far from optimal, especially for predicting receipt 
of organ support. This is arguably unsurprising since they 
were developed for a variety of purposes and none were 
derived using data from patients presenting to the ED with 
suspected COVID-19. Research to derive and validate triage 
tools specific for COVID-19 is therefore an urgent priority.
Author affiliations
1ScHARR, The University of Sheffield, Sheffield, UK
2Acute intensive Care Unit, Wythenshawe Hospital, Manchester University NHS 
Foundation Trust, Manchester, UK
3Emergency Department, Lancashire Teaching Hospitals NHS Foundation Trust, 
Chorley, UK
4Sheffield Children’s Hospital NHS Foundation Trust, Sheffield, UK
5Emergency Department, Sheffield Children’s Hospital NHS Foundation Trust, 
Sheffield, UK
6Department of Emergency Medicine, Royal London Hospital, London, UK
7Paediatric ED, Imperial College Healthcare NHS Trust, London, UK
8Emergency Department, University Hospital of South Manchester NHS Foundation 
Trust, Manchester, UK
Twitter Tim Harris @tim harris@resusdocs and Darren Walter @emsdocuk
Acknowledgements We thank Katie Ridsdale for clerical assistance with the 
study, Erica Wallis (sponsor representative), all members of the Study Steering 
Committee (online supplemental appendix 2) and the site research teams who 
delivered the data for the study (online supplemental appendix 3), and the research 
team at The University of Sheffield past and present (online supplemental appendix 
4).
Contributors SG, AB, KC, CF, TH, FL, ALe, IM and DW conceived and designed the 
study. BT, KB, ALo, SW, RS, JS, SC, ES, JH and EY acquired the data. EL, LS, MB, SG, BT, 
KB and CM analysed the data. SG, AB, KC, CF, TH, FL, ALe, IM, DW, EL, LS, SG, BT, KB 
and CM interpreted the data. All authors contributed to drafting the manuscript. BT 
is the guarantor of the paper.
Funding The PRIEST study was funded by the UK National Institute for Health 
Research Health Technology Assessment (HTA) programme (project reference 
11/46/07).
Disclaimer The funder played no role in the study design; in the collection, analysis 
and interpretation of data; in the writing of the report; and in the decision to submit 
the article for publication. The views expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval The North West- Haydock Research Ethics Committee 
gave a favourable opinion on the PAINTED study on 25 June 2012 (reference 
12/NW/0303) and on the updated PRIEST study on 23 March 2020. The 
Confidentiality Advisory Group of the Health Research Authority granted approval 
to collect data without patient consent in line with Section 251 of the NHS Act 
2006.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available in a public, open- access 
repository. Data are available upon reasonable request. Anonymised data are 
available from the corresponding author upon reasonable request (contact details on 
first page).
Supplemental material This content has been supplied by the author(s). 
It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not 
have been peer- reviewed. Any opinions or recommendations discussed are 
solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all 
liability and responsibility arising from any reliance placed on the content. 
Where the content includes any translated material, BMJ does not warrant the 
accuracy and reliability of the translations (including but not limited to local 
regulations, clinical guidelines, terminology, drug names and drug dosages), and 
is not responsible for any error and/or omissions arising from translation and 
adaptation or otherwise.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iDs
Ben Thomas http:// orcid. org/ 0000- 0002- 6659- 6930
Steve Goodacre http:// orcid. org/ 0000- 0003- 0803- 8444
Carl Marincowitz http:// orcid. org/ 0000- 0003- 3043- 7564
Sarah Connelly http:// orcid. org/ 0000- 0001- 9963- 5628
REFERENCES
 1 NHS. Clinical guide for the management of emergency department patients during the 
coronavirus pandemic. Available: https://www. england. nhs. uk/ coronavirus/ secondary- 
care/ other- resources/ specialty- guides/# ae [Accessed 27 Aug 2020].
 2 American College of Emergency Physicians. Guide to coronavirus disease (COVID-19). 
Available: https://www. acep. org/ corona/ covid- 19- field- guide/ cover- page/ [Accessed 
27 Aug 2020].
 3 The PRIEST Research Group. Characterisation of 22446 patients attending UK 
emergency departments with suspected COVID-19 infection: Observational cohort 
study [Preprint]. medRxiv:2020.08.10.20171496.
 4 World Health Organisation. Clinical care of severe acute respiratory infections – tool 
kit. Available: https://www. who. int/ publications- detail/ clinical- care- of- severe- acute- 
respiratory- infections- tool- kit [Accessed 27 Aug 2020].
 5 National Institute for Health and Care Excellence. COVID-19 rapid guideline: 
managing suspected or confirmed pneumonia in adults in the community, 2020. 
Available: www. nice. org. uk/ guidance/ ng165 [Accessed 27 Aug 2020].
 6 Royal College of Physicians. National early warning score (news) 2: standardising the 
assessment of acute- illness severity in the NHS. updated report of a working Party. 
London: RCP, 2017.
 7 Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia 
severity on presentation to hospital: an international derivation and validation study. 
Thorax 2003;58:377–82.
 8 Challen K, Bright J, Bentley A, et al. Physiological- social score (PMEWS) vs. CURB-65 
to triage pandemic influenza: a comparative validation study using community- 
acquired pneumonia as a proxy. BMC Health Serv Res 2007;7:33.
 9 Department of Health. Swine flu clinical package. London: Department of Health, 
2009.
 10 Public Health England. COVID-19: investigation and initial clinical management of 
possible cases. Available: https://www. gov. uk/ government/ publications/ wuhan- novel- 
coronavirus- initial- investigation- of- possible- cases/ investigation- and- initial- clinical- 
management- of- possible- cases- of- wuhan- novel- coronavirus- wn- cov- infection# criteria 
[Accessed 27 Aug 2020].
 11 Goodacre S, Irving A, Wilson R, et al. The pandemic influenza triage in the emergency 
department (painted) pilot cohort study. Health Technol Assess 2015;19:1–70.
 12 StataCorp. Stata statistical software: release 16. College Station, TX: StataCorp LLC, 
2019.
 13 Hirst E, Irving A, Goodacre S. Patient and public involvement in emergency care 
research. Emerg Med J 2016;33:665–70.
 14 Goodacre S, Challen K, Wilson R, et al. Evaluation of triage methods used to select 
patients with suspected pandemic influenza for hospital admission: cohort study. 
Health Technol Assess 2010;14:173–263.
 15 Rowan KM, Harrison DA, Walsh TS, et al. The swine flu triage (swift) study: 
development and ongoing refinement of a triage tool to provide regular information 
to guide immediate policy and practice for the use of critical care services during the 
H1N1 swine influenza pandemic. Health Technol Assess 2010;14:337–496.
7Thomas B, et al. Emerg Med J 2021;0:1–7. doi:10.1136/emermed-2020-210783
Original research
 16 Muller MP, McGeer AJ, Hassan K, et al. Evaluation of pneumonia severity and acute 
physiology scores to predict ICU admission and mortality in patients hospitalized for 
influenza. PLoS One 2010;5:e9563.
 17 Fan G, Tu C, Zhou F. Comparison of severity scores for COVID-19 patients with 
pneumonia: a retrospective study. Eur Respir J2020.
 18 Bradley P, Frost F, Tharmaratnam K, et al. The utility of established prognostic scores 
in COVID-19 hospital admissions: a multicenter prospective evaluation of CURB-65, 
NEWS2, and qSOFA [Preprint]. medRxiv:2020.07.15.20154815.
 19 Ma X, Ng M, Xu S, et al. Development and validation of prognosis model of mortality 
risk in patients with COVID-19. Epidemiol Infect 2020;148:e168.
 20 Satici C, Demirkol MA, Sargin Altunok E, et al. Performance of pneumonia severity 
index and CURB-65 in predicting 30- day mortality in patients with COVID-19. Int J 
Infect Dis 2020;98:84–9.
 21 Nguyen Y, Corre F, Honsel V, et al. Applicability of the CURB-65 pneumonia severity 
score for outpatient treatment of COVID-19. J Infect 2020;81:e96–8.
 22 Gidari A, De Socio GV, Sabbatini S, et al. Predictive value of national early warning 
score 2 (NEWS2) for intensive care unit admission in patients with SARS- CoV-2 
infection. Infect Dis 2020;52:698–704.
 23 Myrstad M, Ihle- Hansen H, Tveita AA, et al. National Early Warning Score 2 (NEWS2) 
on admission predicts severe disease and in- hospital mortality from Covid-19 - a 
prospective cohort study. Scand J Trauma Resusc Emerg Med 2020;28:66.
